Evidence map›Paper›PMID 31414226›Full record

ArticleRheumatology international2020

Peripheral blood mononuclear cell proteome profile in Behçet's syndrome.

Asli Kirectepe Aydin, Yeşim Özgüler, Didar Uçar, Murat Kasap, Gürler Akpınar, Emire Seyahi, Eda Tahir Turanli

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. DIGE Analysis of Clinical Specimens.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Asli Kirectepe AydinDepartment of Molecular Biology-Genetics and Biotechnology, Graduate School of Science, Engineering and Technology, İstanbul Technical University, İstanbul, Turkey.ORCID http://orcid.org/0000-0001-8289-5191
Yeşim ÖzgülerDivision of Rheumatology, Department of Internal Medicine, Cerrahpaşa Medical Faculty, İstanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-2082-4715
Didar UçarDivision of Ophthalmology, Department of Surgical Medicine, Cerrahpaşa Medical Faculty, İstanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-3469-7307
Murat KasapDepartment of Medical Biology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.ORCID http://orcid.org/0000-0001-8527-2096
Gürler AkpınarDepartment of Medical Biology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.ORCID http://orcid.org/0000-0002-9675-3714
Emire SeyahiDivision of Rheumatology, Department of Internal Medicine, Cerrahpaşa Medical Faculty, İstanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-4965-2918
Eda Tahir TuranliDepartment of Molecular Biology and Genetics, Dr. Orhan Öcalgiray, Molecular Biology-Biotechnology and Genetics Research Centre (MOBGAM), Graduate School of Science, Engineering and Technology, Istanbul Technical University, Ayazağa Campus, 34469, Istanbul, Maslak, Turkey. turanlie@itu.edu.tr.ORCID http://orcid.org/0000-0002-0789-0398
Istanbul University-Cerrahpaşa · TRIstanbul Technical University · TRKocaeli Üniversitesi · TR

Funding

Istanbul Teknik Üniversitesi 37800Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 113S904
6 · The paper itself

Abstract

Behçet's syndrome (BS) is a systemic inflammatory disorder with unknown etiology. Investigation of proteome profiles of disease specific cells facilitates our understanding of the processes and related molecular pathways, especially in disorders like BS with complex inheritance pattern and clinical heterogeneity. In the current study, we evaluated the peripheral blood mononuclear cells (PBMCs) proteome of 59 patients with BS (33 in active and 26 in inactive phases) and of 28 healthy controls using two-dimensional fluorescence difference gel electrophoresis (2D-DIGE). Differentially expressed protein spots with at least twofold and/or statistically significant change (p ≤ 0.05) between active BS vs inactive BS, and also active BS vs healthy controls were identified by mass spectrometry (MALDI-TOF/TOF). Bioinformatic analyses revealed 16 differentially expressed proteins (12 of them in active vs inactive BS comparison, whereas 11 of them for active BS vs healthy control comparison) belonging to glycolysis, cytoskeleton organization, protein folding, and regulation of blood coagulation pathways. Stathmin (active BS vs inactive BS; fourfold, active BS vs healthy control; 4.7-fold) and WD repeat-containing protein-1 (active BS vs inactive BS; 2.7-fold, active BS vs healthy control; 2.7-fold), which are cytoskeleton-related proteins, were found to be lower in active patients compared to inactive patients and healthy control. Decreased levels of calreticulin (active BS vs inactive BS; 1.29-fold) and heat shock 70 kDa protein 8 (active BS vs healthy control; 1.5-fold) which are involved in protein folding and endoplasmic reticulum (ER) stress process, were observed in patients with active phase of BS. Down-regulation of protein folding and ER stress process proteins in BS patients may further support the involvement of ER stress in BS.

Indexed as

AdultBehcet SyndromeCase-Control StudiesColchicineElectrophoresis, Gel, Two-DimensionalFemaleHumansImmunosuppressive AgentsLeukocytes, MononuclearMaleProteomeProteomicsSeverity of Illness IndexSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTubulin ModulatorsYoung AdultColchicineImmunosuppressive AgentsProteomeTubulin Modulators2D-DIGEBehçet’s syndromeER stressProteome

Identifiers

PMID31414226
OpenAlexW2967647188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.